文献速递免疫规划卫生政策与健康促进

私人部门常规推荐成人疫苗的保险报销情况

Insurance Reimbursements for Routinely Recommended Adult Vaccines in the Private Sector.
PubMed 文献 · Am J Prev Med · 2019-06-25

该研究基于2016年MarketScan商业理赔数据库,分析19-64岁成人接种四种常规推荐疫苗的保险报销。结果显示,多数疫苗接种访问的报销额超过CDC公布价格,但各州差异较大,Td疫苗仅25.8%访问报销超过CDC价格。

要点

  • 成人疫苗管理报销首剂平均25.80美元,同次额外剂次平均14.71美元。
  • Tdap、带状疱疹和多数流感疫苗的报销额多数超过CDC公布价格。
  • Td疫苗仅25.8%的接种访问报销额超过CDC公布价格。

核心结论

  • 私人保险成人疫苗接种的平均报销对多数私人诊所是充足的,但提供者的财务担忧可能因地理位置而异。

研究设计与样本

  • 2018年开展的横断面研究,使用2016年MarketScan商业理赔与 encounters 数据库,纳入19-64岁成人的疫苗接种访问。

主要发现

  • 疫苗管理报销首剂平均25.80美元,同次额外剂次平均14.71美元。
  • 疫苗采购报销Tdap平均44.15美元,Td平均25.78美元,带状疱疹疫苗平均216.05美元,四种流感疫苗未加权平均17.25美元。
  • 报销额在各州间差异很大。
  • Tdap接种访问中71.4%报销超过CDC公布价格,带状疱疹为87.8%,四种流感疫苗中三种为61.5%-88.5%,而Td仅为25.8%。

临床怎么用

  • 私人诊所可参考平均报销水平评估成人疫苗接种服务的财务可行性,并关注本州报销差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Financial concerns are frequently cited by providers as a barrier to adult vaccination. This study assessed insurance reimbursements to providers for administering vaccines to adults in the private sector. METHODS: This study, conducted in 2018, used the 2016 MarketScan Commercial Claims and Encounters Database and included vaccination visits made by adults aged 19-64 years. Four routinely recommended vaccines targeted at adults were included: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap); tetanus and diphtheria toxoids (Td); zoster; and influenza. The mean reimbursements for vaccine purchase and administration were reported and examined by state, metropolitan statistical area, provider type, and insurance plan type. Using the private vaccine purchase price published by the Centers for Disease Control and Prevention (CDC), the study reported the proportion of vaccination visits receiving reimbursements above the CDC-published price. RESULTS: The mean vaccine administration reimbursement was $25.80 for the first dose and $14.71 for additional doses in the same visit. The mean vaccine purchase reimbursement was $44.15 for Tdap, $25.78 for Td, and $216.05 for the zoster vaccine; the unweighted mean for the four examined influenza vaccines was $17.25. Reimbursements varied widely by state. Vaccine reimbursements exceeded the CDC-published price for most visits where Tdap (71.4%), zoster (87.8%), and three of four influenza (61.5%-88.5%) vaccines were administered but only for 25.8% of visits where Td was given. CONCLUSIONS: On average, reimbursements for administering vaccines to privately insured adults were adequate for most private practices. However, providers' financial concerns may vary across geographic locations.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Tsai Y, Zhou F, Lindley MC, et al. Insurance Reimbursements for Routinely Recommended Adult Vaccines in the Private Sector. Am J Prev Med. 2019. PMID: 31248743. doi:10.1016/j.amepre.2019.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。